CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Global Calcium House 1 - 692000 - 07/30/2026

RegulatoryNegative
AI Analysis

Summary

Global Calcium House received a regulatory notice on July 30, 2026 related to CGMP violations and adulterated Active Pharmaceutical Ingredients.

Outcome Details

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Importance:6/10
Sentiment:
-0.80
regulatoryCGMPAPIadulterationFDA
Related Companies

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 6, 2026 7:16 PM

Read Original